Home > Press > Zecotek Receives Russian Patent for MAPD Solid-State Photo Detectors; U.S. and PCT Patents Pending
Abstract:
Zecotek Photonics Inc. (TSX-V:ZMS) (Frankfurt:W1I) today announced that it has been granted full patent rights for its latest Micro-channel Avalanche Photodiode solid-state photo detector by the Agency for Intellectual Property Protection in Russia. Zecotek currently has pending U.S. and PCT (Patent Cooperation Treaty) counterpart applications for worldwide patent rights and anticipates approvals.
"Russia is acknowledged as the leader in the field of photo detection and the granting of Russian patent rights fully endorses the technological breakthroughs we have achieved," said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek. "Of equal importance is the demonstration of the MAPD's commercial viability. We have successfully brought the device into production with the Malaysian Institute for Micro-electronics Systems and initiated sales with significant cost and performance advantages over competing devices."
Zecotek's proprietary and patented MAPDs have been designed in several configurations to offer significant cost and performance advantages over the current vacuum tube based photo multiplier tubes (PMT) and other solid-state photo diodes. Zecotek's MAPD-2 addresses specific, high-demand requirements in high-energy physics such as particle accelerators where PMTs are vulnerable to the magnetic environment created by the superconducting magnets used in the collimation of particle tracks. The MAPD-3 meets required specifications for advanced, high resolution PET (positron emission tomography) scanners and gamma camera applications, particularly when matched with Zecotek's patented LFS scintillation materials. Photo detectors, together with the scintillation material, typically constitute 50 to 65% of the manufacturing cost of a PET scanner.
Existing photo multiplier tubes are also key components of medical inspection devices used in blood analysis and DNA sequencing. Additional non-medical applications include: gamma ray detectors for homeland security, environmental monitoring, industrial control systems, robotics, biomedical testing, navigation and guidance systems, laser radars and high-energy physics.
Zecotek's MAPD solid-state photo detectors are supplied through its wholly owned subsidiary Zecotek Imaging Systems Pte. Ltd., Singapore, and manufactured under contract by the Malaysian Institute of Microelectronic Systems. Technical specifications of the MAPD can be found on the company's website www.zecotek.com.
####
About Zecotek Photonics Inc.
Zecotek Photonics Inc. (TSX-V:ZMS) (Frankfurt:W1I) is a photonics technology company developing leading-edge products: crystals, photo detectors, lasers, imaging and 3D display technologies, for medical, biotech, industrial, nanotech and atomic/molecular science applications. Founded in 2003, the company has three distinct operating divisions: Laser Systems, Imaging Systems and 3D Display Systems and labs located in Canada, the United States, Singapore, Malaysia and Russia. Zecotek commercializes its novel, patented and patent-pending photonic technologies directly and through strategic alliances and joint ventures with multinational OEMs, distributors and other industry leaders.
This press release may contain forward-looking statements that are based on management's expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stat
For more information, please click here
Contacts:
Zecotek Photonics Inc.
Product and technical information:
Susana Mendez Alcala
(604) 827-5232
Corporate information:
Michael Minder, CFO; VP Corporate Development
& Communications
(604) 827-5203
Caliber Capital & Communications
Investor information:
Tim McNulty
(778) 327-6678
Copyright © PrimeNewswire
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
Photonics/Optics/Lasers
Groundbreaking precision in single-molecule optoelectronics August 16th, 2024
Single atoms show their true color July 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||